Dr. Günter Blobel received his M.D. from the University of Tübingen in 1960 and his Ph.D. from the University of Wisconsin, Madison in 1967. He was named the John D. Rockefeller Jr. Professor in 1992 and became an investigator at the Howard Hughes Medical Institute in 1986.
Dr. Blobel was the 1999 recipient of the Nobel Prize in Physiology or Medicine for his discovery that proteins have intrinsic signals that govern their transport and localization in the cell. He also received the King Faisal Award in 1996, the Albert Lasker Award for Basic Medical Research in 1993, the Louisa Gross Horwitz Prize in 1989, and the Gairdner Foundation International Award in 1982.
Dr. de Lange studied biochemistry at the University of Amsterdam and the Dutch Cancer Institute. As part of her undergraduate training, she worked on globin gene expression with Richard Flavell at the NIMR in Mill Hill before joining Piet Borst in 1981 at the Dutch Cancer Institute as a graduate student. In 1985, she obtained her Ph.D. (cum laude) and joined Harold Varmus at the University of California, San Francisco, for postdoctoral studies. With Dr. Varmus, she isolated human telomeric DNA and was the first to show that tumor telomeres shorten. In 1990, she was appointed Assistant Professor at The Rockefeller University, and was promoted to Professor in 1997. She is currently the Leon Hess Professor, an American Cancer Society Research Professor and the Director of the Anderson Center for Cancer Research at Rockefeller.
Dr. de Lange is an elected member of the European Molecular Biology Organization, the U.S. National Academy of Science, the Dutch Royal Academy of Sciences, the American Academy of Arts and Sciences, the American Association for Advancement of Science, the American Society for Microbiology, the New York Academy of Science, the AACR Academy, and the Institute of Medicine.
Dr. de Lange received numerous awards, including the inaugural Paul Marks Prize for Cancer Research (shared), the Massachusetts General Hospital Cancer Center Prize, the AACR's G.H.A. Clowes Awards, the Vilcek Prize, the Vanderbilt Prize, the Dr. H.P. Heineken Prize from the Royal Dutch Academy for Arts and Sciences, the Judd award from Memorial Sloan-Kettering Cancer Center, the Jill Rose Award from the Breast Cancer Research Foundation, theBreakthrough Prize in Life Sciences, and the Canada Gairdner International Award. She holds an honorary degree from the University of Utrecht.
Professor Qais Al-Awqati received his M.B., Ch.B. from the University of Baghdad in 1962. He was named the Robert F. Loeb Professor of Medicine in 1987 and became a Professor of Physiology and Medicine at Columbia University College of Physicians & Surgeons in 1983.
Professor Al-Awqati’s research activities include stem cells, epithelial cell biology, ion channels, and the overall development of the kidney.
Dr. Joan Steitz received her B.S. from Antioch College and her Ph.D. from Harvard University. She is Sterling Professor of Molecular Biophysics and Biochemistry at the Yale School of Medicine.
Dr. Steitz is best known for discovering and defining the function of small nuclear ribonucleoproteins (snRNPs), which occur only in higher cells and organisms. She is also interested in the multiple roles played by small RNA–protein complexes in gene expression in vertebrate cells.
Dr. H. Robert Horovitz received his Ph.D. in 1974 from Harvard University and is David H. Koch Professor of Biology in the MIT Department of Biology; a Member, McGovern Institute for Brain Research; and Investigator, Howard Hughes Medical Institute.
In 2002, he received the Nobel Prize in Physiology or Medicine for discoveries concerning the genetic regulation of organ development and programmed cell death. His research interests focus on how genes control animal development and behavior and the ways this can affect human health.